The global appendicitis treatment market was valued at US$ 4.1 Bn in 2023 and is projected to reach US$ 8.0 Bn by the end of 2034, expanding at a steady CAGR of 6.1% from 2024 to 2034. Market growth is being fueled by the rising incidence of undiagnosed appendicitis, increasing awareness of early symptoms, and the expanding feasibility of non-surgical treatment approaches. Analyst Viewpoint...